Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Gabriel Davi Marena, Matheus Aparecido dos Santos Ramos, Taís Maria Bauab & Marlus Chorilli. (2022) A Critical Review of Analytical Methods for Quantification of Amphotericin B in Biological Samples and Pharmaceutical Formulations. Critical Reviews in Analytical Chemistry 52:3, pages 555-576.
Read now
Read now
Athanasios Tragiannidis, Anastasia Gkampeta, Maria Vousvouki, Eleni Vasileiou & Andreas H. Groll. (2021) Antifungal agents and the kidney: pharmacokinetics, clinical nephrotoxicity, and interactions. Expert Opinion on Drug Safety 20:9, pages 1061-1074.
Read now
Read now
Cecilia Li, Sophie Lev, Desmarini Desmarini, Keren Kaufman-Francis, Adolfo Saiardi, Ana P.G Silva, Joel P. Mackay, Philip E. Thompson, Tania C. Sorrell & Julianne T. Djordjevic. (2017) IP3-4 kinase Arg1 regulates cell wall homeostasis and surface architecture to promote Cryptococcus neoformans infection in a mouse model. Virulence 8:8, pages 1833-1848.
Read now
Read now
Franco Aversa, Alessandro Busca, Anna Candoni, Simone Cesaro, Corrado Girmenia, Mario Luppi, Anna Maria Nosari, Livio Pagano, Luigina Romani, Giuseppe Rossi, Adriano Venditti & Andrea Novelli. (2017) Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use. Journal of Chemotherapy 29:3, pages 131-143.
Read now
Read now
Articles from other publishers (14)
Yihong Zhou, Tao Lu, Yan Li, Yuanyuan Qin, Yanqiu Lu, Qun Tian, Ke Lan, Guoqiang Zhou, Yingmei Qin, Vijay Harypursat, Shunmei Li, Shide Lin & Yaokai Chen. (2023) Severe anemia, severe leukopenia, and severe thrombocytopenia of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated talaromycosis: a subgroup analysis of a prospective multicenter cohort study. BMC Infectious Diseases 23:1.
Crossref
Crossref
Günter Rambach, Bianca Striednig, Magdalena Neurauter, Martin Hermann, Reinhard Würzner, Cornelia Lass-Flörl & Cornelia Speth. (2022) Indications that the Antimycotic Drug Amphotericin B Enhances the Impact of Platelets on Aspergillus. Antimicrobial Agents and Chemotherapy 66:10.
Crossref
Crossref
Mahboobeh Jafari, Samira Sadat Abolmaali, Sedigheh Borandeh, Haniyeh Najafi, Zahra Zareshahrabadi, Reza Heidari, Negar Azarpira, Kamiar Zomorodian & Ali Mohammad Tamaddon. (2022) Amphiphilic hyperbranched polyglycerol nanoarchitectures for Amphotericin B delivery in Candida infections. Biomaterials Advances 139, pages 212996.
Crossref
Crossref
Daniela Baracaldo-Santamaría, Juan David Cala-Garcia, Germán José Medina-Rincón, Luis Carlos Rojas-Rodriguez & Carlos-Alberto Calderon-Ospina. (2022) Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?. Antibiotics 11:5, pages 645.
Crossref
Crossref
Mahboobeh Jafari, Samira Sadat Abolmaali, Ali Mohammad Tamaddon, Kamiar Zomorodian & Bahador Shahriarirad (Sarkari). (2021) Nanotechnology approaches for delivery and targeting of Amphotericin B in fungal and parasitic diseases. Nanomedicine 16:10, pages 857-877.
Crossref
Crossref
Nitin Gupta & Manish Soneja. (2020) Amphotericin-induced pancytopenia in a patient with rhino-orbital mucormycosis. Postgraduate Medical Journal 96:1139, pages 572-572.
Crossref
Crossref
Huolong Liu, Benjamin Rivnay, Ken Avery, Ja Hye Myung, Darby Kozak, Nelson Landrau, Alex Nivorozhkin, Muhammad Ashraf & Seongkyu Yoon. (2020) Optimization of the manufacturing process of a complex amphotericin B liposomal formulation using quality by design approach. International Journal of Pharmaceutics 585, pages 119473.
Crossref
Crossref
Marylou Murray & Paul Hine. (2020) Treating progressive disseminated histoplasmosis in people living with HIV. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Chiara Papalini, Barbara Belfiori, Giovanni Martino, Rita Papili, Lucia Pitzurra, Stefano Ascani & Maria Bruna Pasticci. (2019) An Italian Case of Disseminated Histoplasmosis Associated with HIV. Case Reports in Infectious Diseases 2019, pages 1-5.
Crossref
Crossref
Benjamin Rivnay, Joseph Wakim, Ken Avery, Peter Petrochenko, Ja Hye Myung, Darby Kozak, Seongkyu Yoon, Nelson Landrau & Alex Nivorozhkin. (2019) Critical process parameters in manufacturing of liposomal formulations of amphotericin B. International Journal of Pharmaceutics 565, pages 447-457.
Crossref
Crossref
Mohammad Ashfaq, Mohamed Abdel-Bakky, Mir Tahir Maqbool, Volodymyr Samoylenko, Aziz Abdur Rahman & Ilias Muhammad. (2018) Efficacy of Prosopilosidine from Prosopis glandulosa var. glandulosa against Cryptococcus neoformans Infection in a Murine Model. Molecules 23:7, pages 1674.
Crossref
Crossref
Julianne Teresa Djordjevic & Sophie Lev. (2018) Fungal Secretion: The Next-Gen Target of Antifungal Agents?. Cell Chemical Biology 25:3, pages 233-235.
Crossref
Crossref
Luiza Raquel Grazziotin, Leila Beltrami Moreira & Maria Angelica Pires Ferreira. (2018) COMPARATIVE EFFECTIVENESS AND SAFETY BETWEEN AMPHOTERICIN B LIPID-FORMULATIONS: A SYSTEMATIC REVIEW. International Journal of Technology Assessment in Health Care 34:3, pages 343-351.
Crossref
Crossref
Sarah Santos Gonçalves, Ana Carolina Remondi Souza, Anuradha Chowdhary, Jacques F. Meis & Arnaldo Lopes Colombo. (2016)
Epidemiology and molecular mechanisms of antifungal resistance in
Candida
and
Aspergillus
. Mycoses 59:4, pages 198-219.
Crossref
Crossref